Article
Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
Lung cancer (Amsterdam, Netherlands) - 1 May 2017
Sorber L, Zwaenepoel K, Deschoolmeester V, Van Schil P E Y, Van Meerbeeck J, Lardon F, Rolfo C, Pauwels P
Abstract excerpt
Lung cancer is the predominant cause of cancer-related mortality in the world. The majority of patients present with locally advanced or metastatic non-small-cell lung cancer (NSCLC). Treatment for NSCLC is evolving from the use of cytotoxic chemotherapy to personalized treatment based on molecular alterations. Unfortunately, the quality of the available tumor biopsy and/or cytology material is not always...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.